Published in Pharm Res on December 04, 2010
Applications of nanotechnology for immunology. Nat Rev Immunol (2013) 1.65
Structure and dynamics of highly PEG-ylated sterically stabilized micelles in aqueous media. J Am Chem Soc (2011) 0.97
Cell delivery of therapeutic nanoparticles. Prog Mol Biol Transl Sci (2011) 0.97
Human pancreatic polypeptide in a phospholipid-based micellar formulation. Pharm Res (2012) 0.90
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine (2014) 0.88
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol Pharm (2013) 0.87
VIP-targeted Cytotoxic Nanomedicine for Breast Cancer. Drug Deliv Transl Res (2012) 0.85
Nanotherapeutic approaches for the treatment of rheumatoid arthritis. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.80
Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Inflamm Res (2011) 0.78
Putative effects of potentially anti-angiogenic drugs in rheumatic diseases. Eur J Clin Pharmacol (2013) 0.76
Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells. Drug Deliv Transl Res (2013) 0.76
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing. BMC Bioinformatics (2016) 0.75
Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine (Lond) (2015) 0.75
Nanomedicines for chronic non-infectious arthritis: the clinician's perspective. Nanomedicine (2012) 0.75
Particle-based technologies for osteoarthritis detection and therapy. Drug Deliv Transl Res (2016) 0.75
A new lipid-based nano formulation of vinorelbine. AAPS PharmSciTech (2014) 0.75
Evolving concepts of rheumatoid arthritis. Nature (2003) 14.31
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 7.55
Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08
Therapeutic strategies for rheumatoid arthritis. N Engl J Med (2004) 5.51
Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science (1998) 4.51
A model for the mechanism of human topoisomerase I. Science (1998) 4.10
The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev (2004) 2.04
Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine (2005) 2.00
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis Res Ther (2009) 1.98
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci (2004) 1.63
Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release (2009) 1.54
Effect of blood collection technique in mice on clinical pathology parameters. Hum Gene Ther (2002) 1.48
Reference range data base for serum chemistry and hematology values in laboratory animals. J Toxicol Environ Health (1986) 1.47
Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum (2002) 1.30
The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis. Ageing Res Rev (2002) 1.26
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol (2000) 1.25
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. Cancer Chemother Rep (1972) 1.13
Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol (1999) 1.13
Polymer-bound camptothecin: initial biodistribution and antitumour activity studies. J Control Release (2000) 1.12
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med (Berl) (2001) 1.08
The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum (2004) 1.04
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J Biol Chem (2001) 1.02
Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomedicine (2005) 1.02
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells. Arthritis Rheum (2008) 1.00
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. J Control Release (2003) 1.00
Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages. Arthritis Rheum (2005) 1.00
Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J Cereb Blood Flow Metab (2000) 0.99
Topoisomerase inhibitors as anti-arthritic agents. Inflamm Res (2008) 0.97
A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo. Pharm Res (1999) 0.94
Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells. Chem Biol Interact (2007) 0.92
Toxicity of camptothecin (NSC-100880). Cancer Chemother Rep 3 (1974) 0.92
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies. J Clin Oncol (2003) 0.92
Apoptosis in rheumatoid arthritis: friend or foe. Rheum Dis Clin North Am (2004) 0.92
The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ (2000) 0.91
Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl). Hum Exp Toxicol (1996) 0.88
Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts. Anticancer Drugs (1995) 0.86
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma. Cancer Chemother Pharmacol (2008) 0.83
Treatment of collagen induced arthritis in DBA/1 mice with L-asparaginase. Clin Exp Rheumatol (2002) 0.79
Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin. Peptides (1999) 0.79
Painful lessons. Nat Struct Mol Biol (2005) 0.78
Rapid cardiotonic effects of lipid emulsion infusion*. Crit Care Med (2013) 2.76
Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.47
Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine (2005) 2.00
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci (2004) 1.63
Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy. Am J Med (2006) 1.57
Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee? Chest (2004) 1.54
Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect. Anesthesiology (2014) 1.53
Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res (2003) 1.28
Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest (2004) 1.16
Sensitivity and optimization of localized surface plasmon resonance transducers. ACS Nano (2011) 1.07
Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomedicine (2005) 1.02
Transmission surface-plasmon resonance (T-SPR) measurements for monitoring adsorption on ultrathin gold island films. Chemistry (2002) 1.01
Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration (2004) 1.01
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. J Control Release (2003) 1.00
Nanoparticle nanotubes. Angew Chem Int Ed Engl (2003) 0.98
Biological sensing using transmission surface plasmon resonance spectroscopy. Langmuir (2004) 0.98
Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles. Int J Pharm (2008) 0.95
Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells. Cancer Lett (2008) 0.94
Coordination-based gold nanoparticle layers. J Am Chem Soc (2005) 0.93
A novel peptide nanomedicine against acute lung injury: GLP-1 in phospholipid micelles. Pharm Res (2010) 0.92
Epinephrine induces rapid deterioration in pulmonary oxygen exchange in intact, anesthetized rats: a flow and pulmonary capillary pressure-dependent phenomenon. Anesthesiology (2012) 0.91
Biological sensing and interface design in gold island film based localized plasmon transducers. Anal Chem (2008) 0.89
Low-dose, long-term macrolide therapy in asthma: An overview. Clin Mol Allergy (2004) 0.88
Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer. Nanomedicine (2008) 0.88
Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest (2003) 0.87
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol Pharm (2013) 0.87
VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer. Int J Pharm (2008) 0.87
Optimization of localized surface plasmon resonance transducers for studying carbohydrate-protein interactions. Anal Chem (2011) 0.86
Silica-stabilized gold island films for transmission localized surface plasmon sensing. J Am Chem Soc (2007) 0.86
Stabilization of gold nanoparticle films on glass by thermal embedding. ACS Appl Mater Interfaces (2011) 0.85
PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro. Peptides (2006) 0.85
Liposomal vasoactive intestinal peptide. Methods Enzymol (2005) 0.85
VIP-targeted Cytotoxic Nanomedicine for Breast Cancer. Drug Deliv Transl Res (2012) 0.85
Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles. Peptides (2004) 0.83
Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method. J Nanosci Nanotechnol (2006) 0.83
Human VIP-alpha: a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension. Peptides (2006) 0.83
Sensitivity of transmission surface plasmon resonance (T-SPR) spectroscopy: self-assembled multilayers on evaporated gold island films. Chemistry (2005) 0.82
Micellar nanomedicine of human neuropeptide Y. Nanomedicine (2011) 0.82
Development of amyloid burden in African Green monkeys. Neurobiol Aging (2013) 0.82
Bupivacaine, but not lidocaine, disrupts cardiolipin-containing small biomimetic unilamellar liposomes. Chem Biol Interact (2007) 0.82
Intraosseous lipid emulsion: an effective alternative to IV delivery in emergency situations. Crit Care Med (2014) 0.81
Long-acting, multi-targeted nanomedicine: addressing unmet medical need in acute lung injury. J Biomed Nanotechnol (2009) 0.80
Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo. Peptides (2002) 0.80
A quantitative, real-time assessment of binding of peptides and proteins to gold surfaces. Chemistry (2010) 0.80
Polymer-coated gold island films as localized plasmon transducers for gas sensing. J Phys Chem B (2008) 0.80
Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning. Am J Nephrol (2015) 0.80
Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion. Anesthesiology (2016) 0.79
Chemical deposition of Cu(2)O nanocrystals with precise morphology control. ACS Nano (2014) 0.79
Use of cyclodextrins as a cosmetic delivery system for fragrance materials: linalool and benzyl acetate. AAPS PharmSciTech (2007) 0.79
Raman spectroelectrochemistry of molecules within individual electromagnetic hot spots. J Am Chem Soc (2009) 0.79
Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1--38). J Appl Physiol (1985) (2002) 0.79
Polymyxin B self-associated with phospholipid nanomicelles. Pharm Dev Technol (2011) 0.78
Versatile scheme for the step-by-step assembly of nanoparticle multilayers. Langmuir (2011) 0.78
The saga of obstructive sleep apnea syndrome and daytime hypercapnia: work in progress. Chest (2005) 0.78
Mechanism of morphology transformation during annealing of nanostructured gold films on glass. Phys Chem Chem Phys (2013) 0.78
Dimethyl fumarate regulates histone deacetylase expression in astrocytes. J Neuroimmunol (2013) 0.77
The IS6110 repetitive DNA element of Mycobacterium tuberculosis is not detected in exhaled breath condensate of patients with active pulmonary tuberculosis. Respiration (2007) 0.77
Chronic sinopulmonary inflammatory diseases in adults with undetectable serum IgE in inner-city Chicago: a preliminary observation. Lung (2012) 0.77
Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm. Curr Allergy Asthma Rep (2008) 0.77
Secretin self-assembles and interacts spontaneously with phospholipids in vitro. Peptides (2002) 0.76
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis. J Neuroinflammation (2012) 0.76
Divergent growth of coordination dendrimers on surfaces. J Am Chem Soc (2006) 0.76
Pig in a poke: species specificity in modeling lipid resuscitation. Anesth Analg (2011) 0.76
Direct observation of aminoglycoside-RNA binding by localized surface plasmon resonance spectroscopy. Anal Chem (2013) 0.76
All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo. Peptides (2005) 0.76
Branched coordination multilayers on gold. J Am Chem Soc (2005) 0.76
Brain nanomedicine up the nose. Nanomedicine (Lond) (2012) 0.75
A new lipid-based nano formulation of vinorelbine. AAPS PharmSciTech (2014) 0.75
E. coli lipopolysaccharide attenuates adenosine A(1) receptor-mediated increase in plasma exudation from the hamster cheek pouch. Inflamm Res (2010) 0.75
Oral insulin: active targeting to the intestinal mucosa. Nanomedicine (Lond) (2012) 0.75
Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters. Int J Pharm (2006) 0.75
Reporting data on exhaled breath condensate. Am J Respir Crit Care Med (2003) 0.75
Upper airway inflammation in obstructive sleep apnea. Am J Respir Crit Care Med (2002) 0.75
Lipid resuscitation reverses multidrug-induced cardiogenic shock. J Med Toxicol (2011) 0.75
Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm. Curr Allergy Asthma Rep (2005) 0.75
Clinical manifestations of sarcoidosis among inner-city African-American dwellers. J Natl Med Assoc (2006) 0.75
Oral insulin: déjà vu? Nanomedicine (Lond) (2012) 0.75
Liposomes in ultrasound and gamma scintigraphic imaging. Methods Enzymol (2003) 0.75
Widely-applicable gold substrate for the study of ultrathin overlayers. J Am Chem Soc (2004) 0.75
Conformation-dependent effects of VIP on nociception in rats. Peptides (2003) 0.75
Newly diagnosed tuberculosis in inner-city Chicago: the pulmonary fellow perspective. Respiration (2004) 0.75
Human galanin expresses amphipathic properties that modulate its vasoreactivity in vivo. Peptides (2003) 0.75
Layer-by-layer assembly of ordinary and composite coordination multilayers. Langmuir (2004) 0.75
Template-Free Electroless Plating of Gold Nanowires: Direct Surface Functionalization with Shape-Selective Nanostructures for Electrochemical Applications. ACS Appl Mater Interfaces (2017) 0.75
Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides (2004) 0.75
Assembly of coordination nanostructures via ligand derivatization of oxide surfaces. Langmuir (2006) 0.75